HMGB1 redox-dependent inflammatory activity

The biological activity of extracellular HMGB1 is not determined solely by its release from damaged or activated cells. The oxidation state of its cysteine residues is a critical determinant of its inflammatory function.

HMGB1 contains three redox-sensitive cysteines: C23, C45 and C106. Their oxidation status generates molecular isoforms with distinct biological properties.

In its fully reduced form, in which all three cysteine residues are reduced, HMGB1 can form a complex with CXCL12, promoting chemotaxis through CXCR4 signaling. Conversely, in its disulfide form, characterized by C23–C45 disulfide bond with C106 remaining reduced, HMGB1 activates TLR4/MD-2-dependent pro-inflammatory signaling. In its terminally oxidized form, characterized by the further oxidation of these cysteine residues, HMGB1 generally loses both its chemotactic and cytokine-inducing activities.

This redox-dependent functional switch has important implications for interpreting HMGB1 activity during inflammation and tissue injury. Measuring total HMGB1 alone may not adequately reflect its biological effects, as different redox isoforms can trigger fundamentally different cellular responses. Understanding HMGB1 redox transitions is therefore essential for investigating inflammatory mechanisms and developing more selective HMGB1-targeted therapeutic strategies.

At HMGBiotech, we support research into HMGB1-mediated inflammation by providing redox-defined HMGB1 proteins for investigating isoform-specific biological functions.

Discover our LPS-free recombinant HMGB1 proteins
Read the full article about the study

Shopping Cart